{
    "title": "Pharma giant AstraZeneca gets a shot in the arm after it secures a key approval in the US for a cancer drug",
    "url": "https://www.dailymail.co.uk/money/markets/article-11092385/US-boost-AstraZeneca-cancer-drug-Enhertu.html",
    "date": "2022-08-08",
    "keywords": [
        "drug",
        "astrazeneca",
        "cancer",
        "risk",
        "capital",
        "share",
        "fund",
        "approval",
        "breast",
        "enhertu",
        "broker",
        "shore",
        "growth",
        "driver",
        "end",
        "firm",
        "money",
        "platform",
        "investment",
        "account",
        "fee",
        "shot",
        "arm",
        "kind",
        "use",
        "form",
        "half",
        "treatment",
        "food",
        "administration",
        "fdas",
        "phase",
        "trial",
        "disease",
        "progression",
        "death",
        "cent",
        "chemotherapy",
        "boost",
        "lynparza",
        "industry",
        "momentum",
        "article",
        "diy",
        "fda",
        "warning",
        "lung",
        "scarring",
        "toxicity",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}